Cargando…

Formyl Peptide Receptors and Annexin A1: Complementary Mechanisms to Infliximab in Murine Experimental Colitis and Crohn’s Disease

Non-responsiveness to anti-TNF-α therapies presents relevant rates in inflammatory bowel disease patients, presenting the need to find biomarkers involved in therapeutic efficacy. Herein, we demonstrate that higher levels of colonic formyl peptide receptor 1 and annexin A1 correlate with histologica...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Paula-Silva, Marina, da Rocha, Gustavo Henrique Oliveira, Broering, Milena Fronza, Queiroz, Maria Luíza, Sandri, Silvana, Loiola, Rodrigo Azevedo, Oliani, Sonia Maria, Vieira, Andrea, Perretti, Mauro, Farsky, Sandra Helena Poliselli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484756/ https://www.ncbi.nlm.nih.gov/pubmed/34603288 http://dx.doi.org/10.3389/fimmu.2021.714138

Ejemplares similares

Annexin A1/Formyl Peptide Receptor Pathway Controls Uterine Receptivity to the Blastocyst
por: Hebeda, Cristina B., et al.
Publicado: (2020)

Pioglitazone-Mediated Attenuation of Experimental Colitis Relies on Cleaving of Annexin A1 Released by Macrophages
por: da Rocha, Gustavo Henrique Oliveira, et al.
Publicado: (2020)

Role of Annexin A1 Secreted by Neutrophils in Melanoma Metastasis
por: Sandri, Silvana, et al.
Publicado: (2023)

Cellular and Molecular Mechanisms of Environmental Pollutants on Hematopoiesis
por: Scharf, Pablo, et al.
Publicado: (2020)

The Role of Annexin A1 in DNA Damage Response in Placental Cells: Impact on Gestational Diabetes Mellitus
por: Moreli, Jusciele Brogin, et al.
Publicado: (2023)

Annexin 1 localisation in tissue eosinophils as detected by electron microscopy.
por: Oliani, Sonia M, et al.
Publicado: (2002)

Annexin A1(2–26) Treatment Improves Skin Heterologous Transplantation by Modulating Inflammation and Angiogenesis Processes
por: Lacerda, Jéssica Zani, et al.
Publicado: (2018)

Mesoglycan connects Syndecan‐4 and VEGFR2 through Annexin A1 and formyl peptide receptors to promote angiogenesis in vitro
por: Pessolano, Emanuela, et al.
Publicado: (2021)

Dysregulation of Anti-Inflammatory Annexin A1 Expression in Progressive Crohns Disease
por: Sena, Angela, et al.
Publicado: (2013)

Endogenous Annexin-A1 Negatively Regulates Mast Cell-Mediated Allergic Reactions
por: Sinniah, Ajantha, et al.
Publicado: (2019)

Annexin A1 regulates neutrophil clearance by macrophages in the mouse bone marrow
por: Dalli, Jesmond, et al.
Publicado: (2012)

Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis
por: Damazo, Amílcar S, et al.
Publicado: (2011)

Annexin A1 Released in Extracellular Vesicles by Pancreatic Cancer Cells Activates Components of the Tumor Microenvironment, through Interaction with the Formyl-Peptide Receptors
por: Novizio, Nunzia, et al.
Publicado: (2020)

Infliximab in the treatment of Crohn’s disease
por: Poggioli, Gilberto, et al.
Publicado: (2007)

Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn's Disease
por: Gomes, Luis Eduardo Miani, et al.
Publicado: (2019)

Infliximab for medical induction of remission in Crohn's disease
por: Gordon, Morris, et al.
Publicado: (2023)

The impact of endogenous annexin A1 on glucocorticoid control of inflammatory arthritis
por: Patel, Hetal B, et al.
Publicado: (2012)

The restorative role of annexin A1 at the blood–brain barrier
por: McArthur, Simon, et al.
Publicado: (2016)

Neutrophil depletion in the pre-implantation phase impairs pregnancy index, placenta and fetus development
por: Hebeda, Cristina Bichels, et al.
Publicado: (2022)

Pioglitazone Attenuates the Effects of Peripheral Inflammation in a Human In Vitro Blood–Brain Barrier Model
por: da Rocha, Gustavo Henrique Oliveira, et al.
Publicado: (2022)

Formyl peptide receptor type 2 agonists to kick‐start resolution pharmacology
por: Perretti, Mauro, et al.
Publicado: (2020)

Infliximab to treat Crohn’s disease: an update
por: Cottone, M, et al.
Publicado: (2011)

The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease
por: Vande Casteele, Niels, et al.
Publicado: (2015)

Annexin A1 Induces Skeletal Muscle Cell Migration Acting through Formyl Peptide Receptors
por: Bizzarro, Valentina, et al.
Publicado: (2012)

Estrogen Promotes Pro-resolving Microglial Behavior and Phagocytic Cell Clearance Through the Actions of Annexin A1
por: Loiola, Rodrigo Azevedo, et al.
Publicado: (2019)

Profile of infliximab in the treatment of pediatric Crohn’s disease
por: Kierkus, Jaroslaw, et al.
Publicado: (2015)

Metastatic Crohn’s disease despite infliximab therapy
por: Campos, Sara, et al.
Publicado: (2017)

Myelolipoma After Infliximab Treatment for Crohn's Disease
por: Cesa, Kevin, et al.
Publicado: (2022)

Gummatous cutaneous tuberculosis associated with the use of infliximab for Crohn's disease()()
por: Garcia, Lucas Campos, et al.
Publicado: (2021)

Population pharmacokinetics of subcutaneous infliximab CT‐P13 in Crohn’s disease and ulcerative colitis
por: Hanzel, Jurij, et al.
Publicado: (2021)

Infliximab Originator, Infliximab Biosimilar, and Adalimumab Are More Effective in Crohn's Disease Than Ulcerative Colitis: A Real-Life Cohort Study
por: Barberio, Brigida, et al.
Publicado: (2020)

Extracellular annexin-A1 promotes myeloid/granulocytic differentiation of hematopoietic stem/progenitor cells via the Ca(2+)/MAPK signalling transduction pathway
por: Barbosa, Christiano M. V., et al.
Publicado: (2019)

ANNEXIN A1: Roles in Placenta, Cell Survival, and Nucleus
por: de Sousa, Stefanie Oliveira, et al.
Publicado: (2022)

Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn’s disease
por: Oh, Eun Hye, et al.
Publicado: (2017)

Demodicosis as an opportunistic infection in a patient with Crohn’s disease treated with infliximab
por: Niedźwiedź, Michał, et al.
Publicado: (2022)

Infliximab therapy in pediatric Crohn’s disease: a review
por: Parashette, Kalyan Ray, et al.
Publicado: (2010)

Maintenance treatment with infliximab for the management of Crohn’s disease in adults
por: Caviglia, Renato, et al.
Publicado: (2009)

Infliximab-induced intertriginous psoriasis in patient with Crohn's disease
por: Mola, Federica, et al.
Publicado: (2011)

Refractory Duodenal Crohn's Disease Successfully Treated with Infliximab
por: Kim, You Lim, et al.
Publicado: (2014)

Infliximab in the Treatment of Crohn Disease and Type 1 Diabetes
por: Timper, Katharina, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_29jndkfnbqbv7rd32ikcoesc2a